BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21390499)

  • 1. Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.
    Schairer C; Brown LM; Mai PL
    Breast Cancer Res Treat; 2011 Aug; 129(1):117-24. PubMed ID: 21390499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.
    Hirko KA; Soliman AS; Banerjee M; Ruterbusch J; Harford JB; Merajver SD; Schwartz K
    Breast J; 2014; 20(2):185-91. PubMed ID: 24372839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
    El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
    Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of contralateral breast cancer: a SEER-based analysis.
    Giannakeas V; Lim DW; Narod SA
    Br J Cancer; 2021 Aug; 125(4):601-610. PubMed ID: 34040177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
    Aurit SJ; Devesa SS; Soliman AS; Schairer C
    Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of invasive breast cancer after lobular intra-epithelial neoplasia: review of the literature.
    Ansquer Y; Delaney S; Santulli P; Salomon L; Carbonne B; Salmon R
    Eur J Surg Oncol; 2010 Jul; 36(7):604-9. PubMed ID: 20541352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
    Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
    Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
    Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
    Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
    Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
    Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.
    Schlichting JA; Soliman AS; Schairer C; Banerjee M; Rozek LS; Schottenfeld D; Harford JB; Merajver SD
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):155-65. PubMed ID: 22028401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
    Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for inflammatory breast cancer and other invasive breast cancers.
    Schairer C; Li Y; Frawley P; Graubard BI; Wellman RD; Buist DS; Kerlikowske K; Onega TL; Anderson WF; Miglioretti DL
    J Natl Cancer Inst; 2013 Sep; 105(18):1373-84. PubMed ID: 24046390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
    Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
    Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
    Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
    Postlewait LM; Teshome M; Adesoye T; DeSnyder SM; Lim B; Kuerer HM; Bedrosian I; Sun SX; Woodward WA; Le-Petross HT; Valero V; Ueno NT; Lucci A
    Ann Surg Oncol; 2021 Dec; 28(13):8610-8621. PubMed ID: 34125346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
    Abraham HG; Xia Y; Mukherjee B; Merajver SD
    Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory breast cancer: a single centre analysis.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
    Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.